Noxxon Pharma is a clinical-stage biotechnology company focused on developing novel therapies targeting the tumor microenvironment for the treatment of aggressive cancers
Noxxon Pharma is a clinical-stage biotechnology company focused on developing novel therapies targeting the tumor microenvironment for the treatment of aggressive cancers. Their lead candidate, NOX-A12, is under development for multiple cancer indications, including glioblastoma and pancreatic cancer.